Tags

glioblastoma patients

IPAX-2 study completes enrolment and confirms dosing for glioblastoma

IPAX-2 study completes enrolment and confirms dosing for glioblastoma

May 19, 2026 | 10:35
Telix Pharmaceuticals announced that the IPAX-2 study of TLX101-Tx has completed patient enrolment and confirmed dosing for newly diagnosed glioblastoma patients.

Latest News

Amplexd Therapeutics initiates phase 2 trial of EGCg-based HPV therapy

Amplexd Therapeutics initiates phase 2 trial of EGCg-based HPV therapy

Knowledge Exchange 2026 explores how artistic intelligence shapes human achievement

Knowledge Exchange 2026 explores how artistic intelligence shapes human achievement

2026 VinFuture Prize receives over 1,800 nominations, network expands fourteenfold

2026 VinFuture Prize receives over 1,800 nominations, network expands fourteenfold

Gardens by the Bay unveils two new Disney-themed family experiences

Gardens by the Bay unveils two new Disney-themed family experiences

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Dinh Hung, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020